Health · India
Dr. Reddy's delays semaglutide supply due to quality concerns
Dr. Reddy's Laboratories has announced a delay in the supply of semaglutide, the active ingredient in popular diabetes and weight loss drugs like Ozempic and Wegovy. The company cited quality issues as the reason for the disruption. This development has impacted the company's stock prices.
How outlets across the spectrum covered it
Left 1 · Centre 1 · Right 0 n = 2
- Left (1): The Hindu
- Centre (1): Mint
- International (1): Bloomberg